Clinical trial · Interventional
Impact on Quality of Life by Moxibustion in Chemotherapy for Cancer
A Pilot Study to Estimate the Efficacy of Moxibustion Stimulation at Abdominal Acupoints on Quality of Life in Cancer Patients Under Chemotherapy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Most cancer patients experience multiple symptoms related to chemotherapy and use CAM (complementary and alternative medicine) as an adjunct to conventional treatment. Moxibustion is traditional Korean medical therapeutic method and uses the heat generated by burning herbal preparations containing Artemisia vulgaris to stimulated acupoint. Herein, the investigators propose an open-label pilot study investigating the effectiveness of moxibustion stimulation at abdominal acupoint on quality of life in cancer patients under chemotherapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Moxibustion | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Moxibustion
- description
- A series of moxibustion sessions within six weeks from baseline with adjuvant chemotherapy.
- interventionNames
- Other: Moxibustion
- type
- NO_INTERVENTION
- label
- Waiting
- description
- Participants who will be allocated to waitlist will receive no moxibustion treatments throughout the 6 weeks while receiving adjuvant chemotherapy
Primary outcomes (1)
- measure
- functional Assessment of Cancer Therapy: General (FACT-G)
- timeFrame
- change from baseline to 6 weeks
Secondary outcomes (3)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnostic histopathology of cancer * Performance status of 0-2 on the European Cooperative Oncology Group (ECOG) performance scale. * Patients on chemotherapy currently have plan to receive chemotherapy for more than 6 weeks. * Follow-up possible during the clinical trial * Informed signed consent Exclusion Criteria: * Patients with Severe Heart disease and hypertension that is not controlled (systolic blood pressure \>160 or Diastolic blood pressure \>100) * Patients with diabetes that is not controlled (FBST \>180 or BST\>250) * Patients with abdominal injury or severe ascites can't be received moxibustion therapy on abdomen. * Hypersensitive section to moxibustion treatment * Inability to comprehend or express oneself in the Korean language * An Individual deemed to be ineligible by a physician * Refusal to participate in this trial or to provide informed consent.
References
Publications (2)
- BACKGROUNDLee MS, Kang JW, Ernst E. Does moxibustion work? An overview of systematic reviews. BMC Res Notes. 2010 Nov 5;3:284. doi: 10.1186/1756-0500-3-284. PMID 21054851
- BACKGROUNDLee MS, Choi TY, Park JE, Lee SS, Ernst E. Moxibustion for cancer care: a systematic review and meta-analysis. BMC Cancer. 2010 Apr 7;10:130. doi: 10.1186/1471-2407-10-130. PMID 20374659